One hundred percent of adult patients with chronic renal failure (CRF) deve
lop cutaneous findings as a result of uremia or due to therapeutic interven
tions. To date, pediatric incidence studies have been limited to Caucasian
children. However, recent reports have indicated that more African American
patients progress to end-stage renal disease (ESRD). This is the first stu
dy to assess the prevalence of renal failure-related skin disease in childr
en of color, including African American and Hispanic patients. Thirty child
ren were evaluated by history and physical examination, with assignment to
one of three treatment categories: transplanted (n = 10), dialyzed (n = 16)
, or medically managed (n = 4). Skin findings were divided into uremic, dru
g-related, or infectious disease types. The incidence of skin disease was 1
00%. Xerosis was the single most common finding, often accompanied by pruri
tus. Cushinoid features were common despite the addition of steroid-sparing
agents. Cyclosporin A-treated African American children had a high inciden
ce of gingival hypertrophy (72%) and an even higher incidence of hypertrich
osis (100%). Acral warts and nevi were common findings, the latter correlat
ing with the length of immunosuppression. There is a high incidence of cosm
etically disfiguring side effects (Cushinoid facies, hypertrichosis, and gi
ngival hypertrophy) in children within all treatment categories, primarily
related to drug treatment. Further study is required to determine the long-
term sequelae, including psychological disturbances, of cutaneous disease i
n children of color with CRF.